लोड हो रहा है...
Immune Checkpoint Therapies in Prostate Cancer
Advanced prostate cancer is the second leading cause of death from cancer in the United States. In the era of cancer immunotherapy, it was the first malignancy to demonstrate improved survival with a cancer-specific vaccine; thus, proving that prostate cancer is an immune responsive disease. However...
में बचाया:
| में प्रकाशित: | Cancer J |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4847149/ https://ncbi.nlm.nih.gov/pubmed/27111907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000176 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|